Blueprint Medicines Corp
NASDAQ:BPMC

Watchlist Manager
Blueprint Medicines Corp Logo
Blueprint Medicines Corp
NASDAQ:BPMC
Watchlist
Price: 88.47 USD -2.22% Market Closed
Market Cap: 5.7B USD
Have any thoughts about
Blueprint Medicines Corp?
Write Note

Wall Street
Price Targets

BPMC Price Targets Summary
Blueprint Medicines Corp

Wall Street analysts forecast BPMC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BPMC is 129.9 USD with a low forecast of 83.83 USD and a high forecast of 177.45 USD.

Lowest
Price Target
83.83 USD
5% Downside
Average
Price Target
129.9 USD
47% Upside
Highest
Price Target
177.45 USD
101% Upside
Blueprint Medicines Corp Competitors:
Price Targets
OCX
OncoCyte Corp
28% Upside
INCY
Incyte Corp
28% Upside
MDGL
Madrigal Pharmaceuticals Inc
27% Upside
002007
Hualan Biological Engineering Inc
31% Upside
STTK
Shattuck Labs Inc
129% Upside
BMRN
Biomarin Pharmaceutical Inc
38% Upside
NRIX
Nurix Therapeutics Inc
130% Upside
PBYI
Puma Biotechnology Inc
30% Upside

Revenue
Forecast

Revenue Estimate
Blueprint Medicines Corp

For the last 8 years the compound annual growth rate for Blueprint Medicines Corp's revenue is 44%. The projected CAGR for the next 3 years is 35%.

44%
Past Growth
35%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Blueprint Medicines Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Blueprint Medicines Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BPMC's stock price target?
Price Target
129.9 USD

According to Wall Street analysts, the average 1-year price target for BPMC is 129.9 USD with a low forecast of 83.83 USD and a high forecast of 177.45 USD.

What is Blueprint Medicines Corp's Revenue forecast?
Projected CAGR
35%

For the last 8 years the compound annual growth rate for Blueprint Medicines Corp's revenue is 44%. The projected CAGR for the next 3 years is 35%.

Back to Top